OnDemand WTP Pricing Research

HHS implements long-awaited 340B drug price transparency rule | Healthcare Finance News

The Department of Health and Human Services will implement the long-delayed final rule for enforcing 340B drug ceiling price transparency, on January 1, 2019.

The rule directs pharmaceutical manufacturers participating in the 340B drug pricing program to disclose the maximum per unit ceiling price that can be charged to 340B hospitals.

Enforcement will be maintained through a closed website available to 340B participating hospitals and providers. Federal regulators will post drug pricing information on the site.

The rule includes monetary penalties for drug companies that overcharge.

Stakeholders said there were numerous instances of drug companies overcharging hospitals, as backed by an Office of Inspector General report.

WHY THIS IS IMPORTANT

The decision ends five delays over eight years since Congress gave HHS the ability to enforce drug price ceilings.

Read complete article here:

HHS implements long-awaited 340B drug price transparency rule | Healthcare Finance News.